Barrington lowered the firm’s price target on Option Care Health (OPCH) to $32 from $40 and keeps an Outperform rating on the shares following the Q3 report. The firm cites the company’s commentary related to the Stelara issue for the target cut.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPCH: